In vivo effects of five different fractions of thymustimulin on haematopoietic recovery of mice treated with cyclophosphamide

E. Balleari, C. Bason, F. Gotta, G. Massa, A. Battaglia, R. Ghio

Research output: Contribution to journalArticle

Abstract

Thymustimulin (TP-1), a thymic extract, has been widely studied for its capacity to induce T-cell proliferation and differentiation. TP-1 has also been shown to exert a stimulatory effect on haematopoiesis both in animal models and in human beings in vivo. In the present set of experiments, we have evaluated the effects of five different fractions of TP-1 on haematopoietic recovery of mice treated with cyclophosphamide (CP), compared to TP-1 in toto. Administration of two different doses (1 and 10 mg/kg) of any of the five TP-1 fractions for 4 consecutive days, together with CP (30 mg/kg), showed that fractions No. 2 (F2), No. 4 (F4) and No. 5 (F5), but not No. 1 (F1) or No. 3 (F3), exerted a protective effect on some of the haematopoietic parameters altered by CP treatment; none of the 5 TP-1 fractions, however, showed the same activity profile as TP-1 in toto. These findings indicate that, in such an experimental model, TP-1 exerts a more complete protective effect on chemotherapy-induced myelotoxicity than any single TP-1 fraction evaluated in the present study.

Original languageEnglish
Pages (from-to)53-62
Number of pages10
JournalInternational Journal of Immunotherapy
Volume12
Issue number3-4
Publication statusPublished - 1996

Fingerprint

Cyclophosphamide
thymostimulin
Hematopoiesis
Cell Differentiation
Theoretical Models
Animal Models
Cell Proliferation
T-Lymphocytes
Drug Therapy

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

In vivo effects of five different fractions of thymustimulin on haematopoietic recovery of mice treated with cyclophosphamide. / Balleari, E.; Bason, C.; Gotta, F.; Massa, G.; Battaglia, A.; Ghio, R.

In: International Journal of Immunotherapy, Vol. 12, No. 3-4, 1996, p. 53-62.

Research output: Contribution to journalArticle

@article{d7e0239abd704cccabb41928afd24da7,
title = "In vivo effects of five different fractions of thymustimulin on haematopoietic recovery of mice treated with cyclophosphamide",
abstract = "Thymustimulin (TP-1), a thymic extract, has been widely studied for its capacity to induce T-cell proliferation and differentiation. TP-1 has also been shown to exert a stimulatory effect on haematopoiesis both in animal models and in human beings in vivo. In the present set of experiments, we have evaluated the effects of five different fractions of TP-1 on haematopoietic recovery of mice treated with cyclophosphamide (CP), compared to TP-1 in toto. Administration of two different doses (1 and 10 mg/kg) of any of the five TP-1 fractions for 4 consecutive days, together with CP (30 mg/kg), showed that fractions No. 2 (F2), No. 4 (F4) and No. 5 (F5), but not No. 1 (F1) or No. 3 (F3), exerted a protective effect on some of the haematopoietic parameters altered by CP treatment; none of the 5 TP-1 fractions, however, showed the same activity profile as TP-1 in toto. These findings indicate that, in such an experimental model, TP-1 exerts a more complete protective effect on chemotherapy-induced myelotoxicity than any single TP-1 fraction evaluated in the present study.",
author = "E. Balleari and C. Bason and F. Gotta and G. Massa and A. Battaglia and R. Ghio",
year = "1996",
language = "English",
volume = "12",
pages = "53--62",
journal = "International Journal of Immunotherapy",
issn = "0255-9625",
publisher = "Bioscience Ediprint Inc.",
number = "3-4",

}

TY - JOUR

T1 - In vivo effects of five different fractions of thymustimulin on haematopoietic recovery of mice treated with cyclophosphamide

AU - Balleari, E.

AU - Bason, C.

AU - Gotta, F.

AU - Massa, G.

AU - Battaglia, A.

AU - Ghio, R.

PY - 1996

Y1 - 1996

N2 - Thymustimulin (TP-1), a thymic extract, has been widely studied for its capacity to induce T-cell proliferation and differentiation. TP-1 has also been shown to exert a stimulatory effect on haematopoiesis both in animal models and in human beings in vivo. In the present set of experiments, we have evaluated the effects of five different fractions of TP-1 on haematopoietic recovery of mice treated with cyclophosphamide (CP), compared to TP-1 in toto. Administration of two different doses (1 and 10 mg/kg) of any of the five TP-1 fractions for 4 consecutive days, together with CP (30 mg/kg), showed that fractions No. 2 (F2), No. 4 (F4) and No. 5 (F5), but not No. 1 (F1) or No. 3 (F3), exerted a protective effect on some of the haematopoietic parameters altered by CP treatment; none of the 5 TP-1 fractions, however, showed the same activity profile as TP-1 in toto. These findings indicate that, in such an experimental model, TP-1 exerts a more complete protective effect on chemotherapy-induced myelotoxicity than any single TP-1 fraction evaluated in the present study.

AB - Thymustimulin (TP-1), a thymic extract, has been widely studied for its capacity to induce T-cell proliferation and differentiation. TP-1 has also been shown to exert a stimulatory effect on haematopoiesis both in animal models and in human beings in vivo. In the present set of experiments, we have evaluated the effects of five different fractions of TP-1 on haematopoietic recovery of mice treated with cyclophosphamide (CP), compared to TP-1 in toto. Administration of two different doses (1 and 10 mg/kg) of any of the five TP-1 fractions for 4 consecutive days, together with CP (30 mg/kg), showed that fractions No. 2 (F2), No. 4 (F4) and No. 5 (F5), but not No. 1 (F1) or No. 3 (F3), exerted a protective effect on some of the haematopoietic parameters altered by CP treatment; none of the 5 TP-1 fractions, however, showed the same activity profile as TP-1 in toto. These findings indicate that, in such an experimental model, TP-1 exerts a more complete protective effect on chemotherapy-induced myelotoxicity than any single TP-1 fraction evaluated in the present study.

UR - http://www.scopus.com/inward/record.url?scp=0030403489&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030403489&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0030403489

VL - 12

SP - 53

EP - 62

JO - International Journal of Immunotherapy

JF - International Journal of Immunotherapy

SN - 0255-9625

IS - 3-4

ER -